{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:17:42Z","timestamp":1761092262517,"version":"build-2065373602"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Facial Plastic Surgery Clinics of North America"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.fsc.2022.03.015","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T18:07:59Z","timestamp":1659636479000},"page":"419-431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Noninvasive Hair Rejuvenation"],"prefix":"10.1016","volume":"30","author":[{"given":"Jordan","family":"Sand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Walen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.fsc.2022.03.015_bib1","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/0190-9622(92)70134-2","article-title":"The psychological effects of androgenetic alopecia in men","volume":"26","author":"Cash","year":"1992","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.fsc.2022.03.015_bib2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0190-9622(93)70223-G","article-title":"Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects","volume":"29","author":"Cash","year":"1993","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"22","key":"10.1016\/j.fsc.2022.03.015_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399402005112","article-title":"Androgenetic alopecia: pathogenesis and potential for therapy","volume":"4","author":"Ellis","year":"2002","journal-title":"Expert Rev Mol Med"},{"issue":"6","key":"10.1016\/j.fsc.2022.03.015_bib4","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/j.1365-2133.2003.05565.x","article-title":"Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors","volume":"149","author":"Severi","year":"2003","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.fsc.2022.03.015_bib5","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/00007611-197511000-00009","article-title":"Male pattern baldness: classification and incidence","volume":"68","author":"Norwood","year":"1975","journal-title":"South Med J"},{"issue":"3","key":"10.1016\/j.fsc.2022.03.015_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","article-title":"Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex","volume":"97","author":"Ludwig","year":"1977","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.fsc.2022.03.015_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/1523-1747.ep12261084","article-title":"Minoxidil stimulates cutaneous blood flow in human balding scalps: pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography","volume":"82","author":"Wester","year":"1984","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.fsc.2022.03.015_bib8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bmj.2.6088.667","article-title":"Minoxidil for severe hypertension after failure of other hypotensive drugs","volume":"ii","author":"Devine","year":"1977","journal-title":"Br Med J"},{"issue":"Suppl 6","key":"10.1016\/j.fsc.2022.03.015_bib9","first-page":"S1","article-title":"European Dermatology Forum (EDF). Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men","volume":"9","author":"Blumeyer","year":"2011","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.fsc.2022.03.015_bib10","series-title":"Practical pediatric dermatology. controversies in diagnosis and treatment","first-page":"187","article-title":"Androgenetic alopecia in adolescents","author":"Alves","year":"2016"},{"issue":"7","key":"10.1016\/j.fsc.2022.03.015_bib11","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/jdv.13324","article-title":"Effect of minoxidil topical foam on frontotemporal and vertex androgenetic alopecia in men: a 104-week open-label clinical trial","volume":"30","author":"Kanti","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.fsc.2022.03.015_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1067\/mjd.2002.124088","article-title":"A\u00a0randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men","volume":"47","author":"Olsen","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.fsc.2022.03.015_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jdv.14624","article-title":"Evidence-based(S3) guideline for the treatment of androgenetic alopecia in women and in men \u2013 short version","volume":"32","author":"Kanti","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3 Pt 2","key":"10.1016\/j.fsc.2022.03.015_bib14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0190-9622(87)70087-5","article-title":"Safety and efficacy of topical minoxidil in the management of androgenetic alopecia","volume":"16","author":"Rietschel","year":"1987","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.fsc.2022.03.015_bib15","first-page":"991","article-title":"The effects of finasteride (Proscar) on hair growth, hair cycle stage, and serum testosterone and dihydrotestosterone in adult male and female stumptail macaques (Macaca arctoides)","volume":"79","author":"Rhodes","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.fsc.2022.03.015_bib16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.jidsp.5640230","article-title":"Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women","volume":"4","author":"Whiting","year":"1999","journal-title":"J\u00a0Investig Dermatol Symp Proc"},{"issue":"4","key":"10.1016\/j.fsc.2022.03.015_bib17","first-page":"550","article-title":"The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia","volume":"41","author":"Drake","year":"1999","journal-title":"J\u00a0Amacad Dermatol"},{"issue":"1","key":"10.1016\/j.fsc.2022.03.015_bib18","first-page":"32","article-title":"Finasteride improves male pattern hair loss in a randomized study in identical twins","volume":"12","author":"Stough","year":"2002","journal-title":"Eur J Dermatol"},{"issue":"10","key":"10.1016\/j.fsc.2022.03.015_bib19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archdermatol.2010.256","article-title":"Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review","volume":"146","author":"Mella","year":"2010","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.fsc.2022.03.015_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1468-3083.2010.03758.x","article-title":"5 mg\/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss","volume":"25","author":"Yeon","year":"2011","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5, pt 1","key":"10.1016\/j.fsc.2022.03.015_bib21","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1067\/mjd.2000.107953","article-title":"Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia","volume":"43","author":"Price","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.fsc.2022.03.015_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003495-199957010-00014","article-title":"A\u00a0review of its use in male pattern hair loss","volume":"57","author":"McClellan","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.fsc.2022.03.015_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000497362","article-title":"Post-Finasteride Syndrome: An Induced Delusional Disorder with the Potential of a Mass Psychogenic Illness?","volume":"5","author":"Tr\u00fceb","year":"2019","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.fsc.2022.03.015_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/0974-7753.114709","article-title":"Finasteride 5 mg\/day treatment of patterned hair loss in normo-androgenetic postmenopausal women","volume":"5","author":"Oliveira-Soares","year":"2013","journal-title":"Int J Trichol"},{"key":"10.1016\/j.fsc.2022.03.015_bib25","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/ijd.14370","article-title":"The efficacy and use of finasteride in women: a systematic review","volume":"58","author":"Hu","year":"2019","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.fsc.2022.03.015_bib26","first-page":"58","article-title":"Biological effects of low level laser therapy","volume":"5","author":"Farivar","year":"2014","journal-title":"J\u00a0Laser Med Sci"},{"key":"10.1016\/j.fsc.2022.03.015_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1034\/j.1600-0722.2000.00783.x","article-title":"Inhibitory effect of low-level laser irradiation on LPS-stimulated prostaglandin E2 production and cyclooxygenase-2 in human gingival fibroblasts","volume":"108","author":"Sakurai","year":"2000","journal-title":"Eur J Oral Sci"},{"key":"10.1016\/j.fsc.2022.03.015_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000509001","article-title":"Examining the safety and efficacy of low-level laser therapy for male and female pattern hair loss: a review of the literature","volume":"6","author":"Egger","year":"2020","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.fsc.2022.03.015_bib29","article-title":"The Effectiveness of Low-Level Light\/Laser Therapy on Hair Loss","author":"Gentile","year":"2021","journal-title":"Facial Plast Surg Aesthet Med"},{"issue":"2","key":"10.1016\/j.fsc.2022.03.015_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10103-017-2385-5","article-title":"Low-level laser therapy for the treatment of androgenic alopecia: a review","volume":"33","author":"Darwin","year":"2018","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.fsc.2022.03.015_bib31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/DSS.0000000000000924","article-title":"Microneedling: a comprehensive review","volume":"43","author":"Hou","year":"2017","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.fsc.2022.03.015_bib32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/2229-5178.185468","article-title":"Microneedling: advances and widening horizons","volume":"7","author":"Singh","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.fsc.2022.03.015_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/0974-7753.114700","article-title":"A\u00a0randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study","volume":"5","author":"Dhurat","year":"2013","journal-title":"Int J Trichol"},{"key":"10.1016\/j.fsc.2022.03.015_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/JCAS.JCAS_130_17","article-title":"A\u00a0randomized controlled single-observer blinded study to determine the efficacy of topical minoxidil plus microneedling versus topical minoxidil alone in the treatment of androgenetic alopecia","volume":"11","author":"Kumar","year":"2018","journal-title":"J\u00a0Cutan Aesthet Surg"},{"issue":"1","key":"10.1016\/j.fsc.2022.03.015_bib35","doi-asserted-by":"crossref","first-page":"010","DOI":"10.17352\/2455-8605.000037","article-title":"A\u00a0study on the efficacy of microneedling with minoxidil solution versus microneedling with hair multivitamin solution for the treatment of androgenetic alopecia","volume":"6","author":"Neerja","year":"2020","journal-title":"Int J Dermatol Clin Res"},{"issue":"01","key":"10.1016\/j.fsc.2022.03.015_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5005\/jp-journals-10003-1106","article-title":"Platelet-rich plasma in cosmetic surgery","volume":"5","author":"Kang","year":"2013","journal-title":"Int J Otorhinolaryngol Clin"},{"issue":"03","key":"10.1016\/j.fsc.2022.03.015_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/archfaci.7.3.163","article-title":"Modulation of wound response and soft tissue ingrowth in synthetic and allogeneic implants with platelet concentrate","volume":"7","author":"Sclafani","year":"2005","journal-title":"Arch Facial Plast Surg"},{"key":"10.1016\/j.fsc.2022.03.015_bib38","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/01.prs.0000239560.29172.33","article-title":"The role of platelet plasma growth factors in male pattern baldness surgery","volume":"118","author":"Uebel","year":"2006","journal-title":"Plast Reconstr Surg"},{"issue":"04","key":"10.1016\/j.fsc.2022.03.015_bib39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/DSS.0000000000000665","article-title":"Randomized placebo-controlled, double-blind,half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia","volume":"42","author":"Alves","year":"2016","journal-title":"Dermatol Surg"},{"issue":"11","key":"10.1016\/j.fsc.2022.03.015_bib40","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/DSS.0000000000000883","article-title":"Double- blind, placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic alopecia","volume":"42","author":"Puig","year":"2016","journal-title":"Dermatol Surg"},{"issue":"8","key":"10.1016\/j.fsc.2022.03.015_bib41","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.3390\/ijms21082702","article-title":"Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil, Finasteride, and Adult Stem Cell-Based Therapy","volume":"21","author":"Gentile","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.fsc.2022.03.015_bib42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1203475418818073","article-title":"The efficacy of platelet-rich plasma in the field of hair restoration and facial aesthetics-A systematic review and meta-analysis","volume":"23","author":"Gupta","year":"2019","journal-title":"J\u00a0Cutan Med Surg"},{"key":"10.1016\/j.fsc.2022.03.015_bib43","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/jocd.12864","article-title":"Platelet-rich plasma and microneedling improves hair growth in patients of androgenetic alopecia when used as an adjuvant to minoxidil","volume":"18","author":"Jha","year":"2019","journal-title":"J\u00a0Cosmet Dermatol"},{"key":"10.1016\/j.fsc.2022.03.015_bib44","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2006.05.007","article-title":"The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride","volume":"55","author":"Olsen","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.fsc.2022.03.015_bib45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/CIA.S192435","article-title":"The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis","volume":"14","author":"Zhou","year":"2019","journal-title":"Clin Interv Aging"},{"issue":"11","key":"10.1016\/j.fsc.2022.03.015_bib46","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/ijd.12060","article-title":"Effect of dutasteride 0.5 mg\/d in men with androgenetic alopecia recalcitrant to finasteride","volume":"53","author":"Jung","year":"2014","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.fsc.2022.03.015_bib47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/0378-6323.188652","article-title":"Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: a randomized controlled open-label, evaluator-blinded study","volume":"83","author":"Shanshanwal","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"10.1016\/j.fsc.2022.03.015_bib48","first-page":"226","article-title":"Antiandrogenic therapy with ciproterone acetate in female patients who suffer from both androgenetic alopecia and acne vulgaris","volume":"87","author":"Coneac","year":"2014","journal-title":"Clujul Med"},{"issue":"1","key":"10.1016\/j.fsc.2022.03.015_bib49","first-page":"32","article-title":"Androgen dependence of hirsutism, acne and alopecia in women: a prospective analysis of 228 patients investigated for hyperandrogenism","volume":"88","author":"Karrer-Voegeli","year":"2009","journal-title":"Medicine(Baltimore)"},{"key":"10.1016\/j.fsc.2022.03.015_bib50","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2005.06218.x","article-title":"Treatment of female pattern hair loss with oral antiandrogens","volume":"152","author":"Sinclair","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.fsc.2022.03.015_bib51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijwd.2017.01.001","article-title":"Hormonal therapy in female pattern hair loss","volume":"3","author":"Brough","year":"2017","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.fsc.2022.03.015_bib52","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/ijd.13838","article-title":"Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone","volume":"57","author":"Sinclair","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.fsc.2022.03.015_bib53","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000017954","article-title":"Ketoconazole shampoo: effect of long-term use in androgenic alopecia","volume":"196","author":"Pi\u00e9rard-Franchimont","year":"1998","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.fsc.2022.03.015_bib54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0306-9877(03)00264-0","article-title":"Ketocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men","volume":"62","author":"Hugo Perez","year":"2004","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.fsc.2022.03.015_bib55","doi-asserted-by":"crossref","first-page":"e13202","DOI":"10.1111\/dth.13202","article-title":"Topical ketoconazole for the treatment of androgenetic alopecia: a systematic review","volume":"33","author":"Fields","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.fsc.2022.03.015_bib56","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1517\/13543784.2013.784743","article-title":"New investigational drugs for androgenetic alopecia","volume":"22","author":"Valente Duarte De Sousa","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"issue":"5","key":"10.1016\/j.fsc.2022.03.015_bib57","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jaad.2011.05.026","article-title":"A\u00a0randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia","volume":"66","author":"Blume-Peytavi","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.fsc.2022.03.015_bib58","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/09553009214551291","article-title":"Topical or systemic 16,16 Dm prostaglandin E2 or WR-2721 (WR-1065) protects mice from alopecia after fractionated irradiation","volume":"61","author":"Geng","year":"1992","journal-title":"Int J Radiat Biol"},{"issue":"4","key":"10.1016\/j.fsc.2022.03.015_bib59","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/exd.12348","article-title":"Does prostaglandin D2 hold the cure to male pattern baldness?","volume":"23","author":"Nieves","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.fsc.2022.03.015_bib60","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1111\/jdv.15171","article-title":"A\u00a0randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia","volume":"32","author":"Suchonwanit","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.fsc.2022.03.015_bib61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/09546639709160517","article-title":"Topical finasteride in the treatment of androgenic alopecia. Preliminary evaluations after a 16-month therapy course","volume":"8","author":"Mazzarella","year":"1997","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.fsc.2022.03.015_bib62","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40257-018-0387-0","article-title":"Efficacy of topical combination of 0.25% finasteride and 3% minoxidil versus 3% minoxidil solution in female pattern hair loss: a randomized, double-blind, controlled study","volume":"20","author":"Suchonwanit","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.fsc.2022.03.015_bib63","doi-asserted-by":"crossref","first-page":"AB113","DOI":"10.1016\/j.jaad.2015.02.466","article-title":"Efficacy and safety of oral minoxidil 5 mg daily during 24-week treatment in male androgenetic alopecia","volume":"72","author":"Lueangarun","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["Facial Plastic Surgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064740622000323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064740622000323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:23:40Z","timestamp":1761020620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064740622000323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1064740622000323"],"URL":"https:\/\/doi.org\/10.1016\/j.fsc.2022.03.015","relation":{},"ISSN":["1064-7406"],"issn-type":[{"type":"print","value":"1064-7406"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noninvasive Hair Rejuvenation","name":"articletitle","label":"Article Title"},{"value":"Facial Plastic Surgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fsc.2022.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}